EmbersonJLeesKRLydenP. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet2014; 384:1929–35.
2.
PetkovaMRodrigoSLamyC. MR imaging helps predict time from symptom onset in patients with acute stroke: implications for patients with unknown onset time. Radiology2010; 257:782–92.
3.
HeidbuchelHVerhammePAlingsM. European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation. Europace2013; 15:625–51.
4.
SteinerTBöhmMDichgansM. Recommendations for the emergency management of complications associated with the new direct oral anticoagulants (DOACs), apixaban, dabigatran and rivaroxaban. Clin Res Cardiol2013; 102:399–412.
5.
HankeyGJNorrvingBHackeWSteinerT. Management of acute stroke in patients taking novel oral anticoagulants. Int J Stroke2014; 9:627–32.
